PURE Bioscience, Inc.
PURE
$0.0653
$0.00538.83%
OTC PK
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -29.68% | 17.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -29.68% | 17.30% | |||
| Cost of Revenue | -29.00% | 16.08% | |||
| Gross Profit | -30.15% | 18.18% | |||
| SG&A Expenses | -1.14% | 4.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.66% | 6.29% | |||
| Operating Income | -15.63% | 1.88% | |||
| Income Before Tax | -15.82% | 8.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15.82% | 8.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.82% | 8.86% | |||
| EBIT | -15.63% | 1.88% | |||
| EBITDA | -22.80% | 1.83% | |||
| EPS Basic | -14.52% | 8.82% | |||
| Normalized Basic EPS | -18.42% | 2.56% | |||
| EPS Diluted | -14.52% | 8.82% | |||
| Normalized Diluted EPS | -18.42% | 2.56% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||